Pocket Psychiatry

Contents eface v
eword vii
PSYCHIA TRIC ASSESSMENT
Mark Fusunyan, Flannery Merideth, Joshua Salvi, Tim Shea, Marc Weinberg
Mental status exam 1-1
Neuropsychiatric testing 1-6
Commonly used rating scales 1-9
Neuroimaging 1-10
EEG 1-12
PSYCHIATRIC DISORDERS
wri G. Aragam, Baktash Babadi, Jessica E. Becker, Noor Beckwith, Ren Belcher, Samuel Boas,
Allison Brandt, Kristina Cieslak, Julia Cromwell, Daniel J. Daunis Jr., Lauren Deaver, Sam Dotson,
Oscar Gerdner, Fiona Gispen, Elisabeth Hill, Katie Hsih, Geoffrey Liu, Elizabeth N. Madva,
Andy Melaragno, Flannery Merideth, Meghan Musselman, Lucy Ogbu-Nwobodo, Maeve O’Neill,
Nate Praschan, Cordelia Ross, Rachel A. Ross, Leah Shesler, Andrew Skoirchet, Maya Son,
Renee Sorrentino, Jonathan Zebrowski
Attention-deficit/hyperactivity disorder 2-1
Adjustment disorders 2-3
Anxiety disorders 2-6
Autism spectrum disorder 2-14
Autoimmune syndromes 2-18
Autoimmune encephalitis 2-24
Bipolar disorder 2-26
Catatonia and related syndromes 2-32
Chronic pain 2-38
Delirium 2-42
Depressive disorders 2-46
Dissociative disorders 2-48
Eating disorders 2-52
Factitious disorder 2-55
Functional and somatoform disorders 2-59
Impulse control disorders 2-73
Intellectual disability 2-75
Major neurocognitive disorders 2-77
Malingering 2-88
Obsessive–compulsive disorder 2-90
ersonality disorders 2-92
osttraumatic stress disorder 2-99
Psychotic disorders 2-103
Seizures 2-107
Sexual dysfunction 2-109
Sleep disorders 2-116Alcohol use disorder 3-1
Cocaine use 3-4
Marijuana use 3-5
Methamphetamine/stimulant use 3-8
Opioid use disorder 3-9
obacco use 3-13
Other substances 3-15
TIC THERAPIES
kwith, Nicole M. Benson, Joan A. Camprodon, Carlos Fernandez-Robles,
Henry, Joshua Salvi, Tim Shea
Deep brain stimulation (DBS) 4-1
oconvulsive therapy (ECT) 4-2
ranscranial magnetic stimulation 4-5
PSYCHOTHERAPIES
agam, Stephanie Davidson, Oscar Gerdner, Reuben A. Hendler, Katie Hsih,
Lianna Karp, Alok Kanojia, Ran Li, Geoffrey Liu, Jonathan Zebrowski
Brief dynamic/insight-oriented therapies 5-1
e behavioral therapy (CBT) 5-2
e processing therapy 5-5
Dialectical behavior therapy (DBT) 5-6
Good psychiatric management (GPM) 5-8
Interpersonal psychotherapy (IPT) 5-9
Mentalization-based treatment (MBT) 5-11
Mindfulness-based therapies 5-12
Motivational interviewing (MI) 5-14
Psychodynamic psychotherapy (PDP) 5-17
tive therapy 5-20
oup therapy 5-22
Couples therapy 5-24
MEDICATIONS AND SIDE EFFECTS
agam, Noor Beckwith, Rahel Bosson, Kristina Cieslak, Cristina Cusin, Sam Dotson,
Faller, Katie Hsih, Katherine Kilgore, James Luccarelli, Andy Melaragno,
Mladen Nisavic, Nate Praschan, Lisa Rosenfeld, Maya Son, John W. Winkelman
Monoamine oxidase inhibitors (MAOIs) 6-1
ricyclic antidepressants (TCAs) 6-3
otonin and norepinephrine reuptake inhibitors (SNRIs) 6-6
e serotonin reuptake inhibitors (SSRIs) 6-7
Atypical antidepressants 6-11
ytics 6-15
Antiepileptic drugs (AEDs) 6-18
6-28Contents Buprenorphine 6-43
Disulfiram 6-47
Naltrexone 6-48
obacco cessation 6-50
Nutraceuticals 6-52
Common side effects 6-54
Landmark studies in psychopharmacology 6-60
EMERGENCY PSYCHIATRY
Suzanne Bird, Mark Fusunyan, Katie Hsih, Katherine A. Koh, Meghan Musselman,
Nate Praschan, Curtis Wittmann
Medical clearance 7-1
Suicide and risk assessment 7-3
Violence risk assessment 7-5
Agitation 7-7
xidromes 7-13
LEGAL ISSUES
Ren Belcher, Douglas Brennan, Raphaela Gold, Meghan Musselman, Marc Weinberg
oluntary treatment 8-1
arasoff reporting 8-2
Legal standards of competency and sanity 8-4
Mandated reporting 8-6
pacity 8-7
SPECIAL POPULATIONS
Noor Beckwith, Ren Belcher, Philip Cawkwell, Jacci Clauss, Julia Cromwell, Stephanie Davidson,
Sam Dotson, Michal McDowell, Cordelia Ross, Emily Sorg, Kathryn Zagrabbe
egnancy 9-1
Psychiatric illness in the postpartum period 9-6
eastfeeding and psychotropic medication 9-9
eating children with psychiatric illness 9-11
Geriatric psychiatry 9-24
Gender and sexual minority populations 9-27
Homeless patients 9-29
ransplant patients 9-30
Oncology patients 9-34
HIV psychiatry 9-40
ABBREVIATIONS 10-1
INDEX I-1